Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga June 11, 2014 at 08:09 AM EDT Orexigen Therapeutics (NASDAQ: OREX) dipped 12.63% to $5.95 in pre-market trading after the company received three month extension of ... Read More >> Related Stocks: Boeing Co Central EUR Med A Exelon Corp